SEC Form 4 · accession 0001225208-26-007335
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daveen Chopra
Officer — CVP, TMTT, Surgical & IHFM
Period of report
Aug 26, 2026
Accepted (ET)
Aug 26, 2026 · 6:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2026 | M | 31,800 | $72.68 | A | 76,124 | D | |
| Common StockF1 | Aug 26, 2026 | S | 1,154 | $91.7614 | D | 74,970 | D | |
| Common StockF2 | Aug 26, 2026 | S | 30,646 | $90.9922 | D | 44,324 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Acquire) | $72.68 | Aug 26, 2026 | M | 31,800 | D | May 7, 2021 | May 6, 2027 | Common Stock | 31,800 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.